Literature DB >> 22010070

Bisphosphonate related osteonecrosis of the jaws: report of two cases.

Jin-Woo Han1.   

Abstract

Bisphosphonates are compounds used to treat osteoporosis and malignant bone metastasis. Despite the benefits related to the use of these medications, osteonecrosis of the jaws is a significant complication in a subset of patients receiving these drugs. This complication occurs either spontaneously or after a simple dento-alveolar surgery. Recently there were two patients who showed the features of bisphosphonate related osteonecrosis of the jaws (BRONJ) in Gangneung-Wonju National University Dental Hospital. The patients revealed the clinical and radiological features of classical osteomyelitis. This report presents two cases of BRONJ which were examined by plain radiography and computed tomography.

Entities:  

Keywords:  Bisphosphonate; Osteonecrosis; Osteoporosis; Tomography, X-ray Computed

Year:  2011        PMID: 22010070      PMCID: PMC3189537          DOI: 10.5624/isd.2011.41.3.129

Source DB:  PubMed          Journal:  Imaging Sci Dent        ISSN: 2233-7822


  12 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Authors:  Salvatore L Ruggiero; John Fantasia; Eric Carlson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-31

Review 2.  Osteonecrosis of the jaws: what the physician needs to know: practical considerations.

Authors:  Khaled Abughazaleh; Nadia Kawar
Journal:  Dis Mon       Date:  2011-04       Impact factor: 3.800

Review 3.  Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.

Authors:  Giuseppe Ficarra; Francesco Beninati
Journal:  Head Neck Pathol       Date:  2007-12-05

Review 4.  Bisphosphonate-related osteonecrosis of the jaw: an overview.

Authors:  Salvatore L Ruggiero
Journal:  Ann N Y Acad Sci       Date:  2010-09-28       Impact factor: 5.691

5.  Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.

Authors:  Marcin Kos; Joachim F Kuebler; Klaudiusz Luczak; Werner Engelke
Journal:  J Craniomaxillofac Surg       Date:  2009-07-09       Impact factor: 2.078

6.  Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.

Authors:  Christos Magopoulos; Georgios Karakinaris; Zisis Telioudis; Konstantinos Vahtsevanos; Ioannis Dimitrakopoulos; Konstantinos Antoniadis; Sideris Delaroudis
Journal:  Am J Otolaryngol       Date:  2007 May-Jun       Impact factor: 1.808

Review 7.  Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis.

Authors:  G Campisi; O Di Fede; A Musciotto; A Lo Casto; L Lo Muzio; F Fulfaro; G Badalamenti; A Russo; N Gebbia
Journal:  Ann Oncol       Date:  2007-06       Impact factor: 32.976

8.  Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.

Authors:  Cinzia Ortega; Filippo Montemurro; Roberto Faggiuolo; Roberto Vormola; Daniela Nanni; Franco Goia; Marco Ottavio Gilardino; Massimo Aglietta
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

9.  Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.

Authors:  Steven Lehrer; André Montazem; Lakshmi Ramanathan; Melissa Pessin-Minsley; John Pfail; Richard G Stock; Rita Kogan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-06-13

10.  Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.

Authors:  Nicolau Conte-Neto; Alliny S Bastos; Luis C Spolidorio; Rosemary Ac Marcantonio; Elcio Marcantonio
Journal:  Head Face Med       Date:  2011-04-27       Impact factor: 2.151

View more
  2 in total

1.  Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors:  Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Denosumab Related Osteonecrosis of Jaw: a Case Report.

Authors:  Marco Vinícius de Sales Lima; Jaqueline Rizzato; Daniella Varzea Gracindo Marques; Dárcio Kitakawa; Felipe da Silva Peralta; Alexandre Prado Scherma; Luis Felipe C S Carvalho
Journal:  J Oral Maxillofac Res       Date:  2018-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.